Key terms

About ELV

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ELV news

Yesterday 10:37am ET Centene rises, Molina slides following Florida’s managed Medicaid awards Yesterday 7:37am ET Elevance Health,CD&R in primary care delivery pact, terms undisclosed Yesterday 7:00am ET Options Volatility and Implied Earnings Moves This Week, April 15 – April 19, 2024 Yesterday 6:16am ET Molina Healthcare price target lowered to $410 from $440 at Wells Fargo Yesterday 6:15am ET Centene price target raised to $93 from $89 at Wells Fargo Yesterday 6:06am ET Elevance Health (ELV) Receives a Buy from Wells Fargo Yesterday 4:26am ET Barclays Keeps Their Buy Rating on Elevance Health (ELV) Apr 08 6:17am ET Elevance Health (ELV) Receives a Buy from Wells Fargo Mar 29 4:41am ET Analysts and Technical Indicators Agree: These 3 Stocks Are “Strong Buys” – 03/29/2024 Mar 26 6:30am ET Analysts Offer Insights on Healthcare Companies: Walgreens Boots Alliance (WBA), Elevance Health (ELV) and Stoke Therapeutics (STOK) Mar 19 5:50am ET Analysts Conflicted on These Healthcare Names: Illumina (ILMN) and Elevance Health (ELV) Mar 19 12:56am ET Kroger (NYSE:KR) Agrees to Divest Specialty Pharmacy Unit Mar 18 4:16pm ET Kroger to sell specialty pharmacy business to CarelonRx, terms not disclosed Mar 06 6:35am ET Barclays starts health care facilities, managed care group with Neutral view Mar 05 4:30pm ET Elevance Health initiated with an Overweight at Barclays Mar 05 5:12am ET Analysts Are Bullish on These Healthcare Stocks: BridgeBio Pharma (BBIO), Elevance Health (ELV) Mar 04 6:59pm ET Bernstein Sticks to Their Buy Rating for Elevance Health (ELV) Feb 14 6:52pm ET Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV) and Cogent Biosciences (COGT) Jan 29 6:31am ET Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE), Legend Biotech (LEGN) and Elevance Health (ELV) Jan 26 4:56am ET Elevance Health Declares Quarterly Dividend for Shareholders Jan 26 12:50am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevance Health (ELV), Johnson & Johnson (JNJ) and Abbott Labs (ABT) Jan 26 12:42am ET Analysts’ Top Healthcare Picks: Intuitive Surgical (ISRG), Leap Therapeutics (LPTX) Jan 25 7:41am ET Analysts Are Bullish on Top Healthcare Stocks: Elevance Health (ELV), Cibus (CBUS) Jan 25 5:50am ET Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Elevance Health (ELV) and AbbVie (ABBV) Jan 25 12:35am ET Elevance Health: A Robust Buy Rating on Financial Strength and Market Strategy Jan 24 9:15pm ET Elevance Health Poised for Growth Post-2024 Headwinds: Buy Rating Affirmed Jan 24 7:27am ET Elevance Health (NYSE:ELV) Jumps on Exceeding Q4 Estimates Jan 24 6:09am ET Elevance Health reports Medical membership totaled ~47M at Dec. 31, 2023 Jan 24 6:03am ET Elevance Health raises quarterly dividend 10.1% to $1.63 per share Jan 24 6:01am ET Elevance Health sees FY24 adjusted EPS ‘greater than’ $37.10, consensus $37.05 Jan 24 6:00am ET Elevance Health reports Q4 adjusted EPS $5.62, consensus $5.64

No recent press releases are available for ELV

ELV Financials

1-year income & revenue

Key terms

ELV Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ELV Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms